To include your compound in the COVID-19 Resource Center, submit it here.

Coprexa: Pivotal trial data

In an open-label pivotal trial in 55 patients, Coprexa significantly improved annual

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE